Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 4/20 | 0.40 |
| ▸ | RORA | P35398 | 2/20 | 0.37 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | RORB | Q92753 | 2/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.31 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21591023 | 0.85 | RORA (0.48) | RORARORCRORBPLA2G4AFAAH | |
| SCHEMBL10123840 | 0.85 | RORA (0.39) | RORARORCRORBPLA2G4APGR | |
| SCHEMBL10123768 | 0.84 | RORA (0.38) | RORARORCRORBPLA2G4APGR | |
| SCHEMBL13629284 | 0.83 | RORA (0.45) | RORARORCRORBPLA2G4AALDH1A1 | |
| SCHEMBL21591020 | 0.82 | RORA (0.46) | RORARORCRORBPLA2G4AFAAH | |
| SCHEMBL21594496 | 0.82 | RORA (0.46) | RORARORCRORBPLA2G4AFAAH | |
| SCHEMBL31070053 | 0.82 | RORA (0.46) | RORARORCRORBPLA2G4AFAAH | |
| SCHEMBL13629297 | 0.81 | RORA (0.37) | RORARORCRORBPLA2G4APGR | |
| SCHEMBL13932489 | 0.81 | RORA (0.44) | RORARORCRORBPLA2G4AALDH1A1 | |
| SCHEMBL10123708 | 0.81 | PLA2G4A (0.38) | RORARORCRORBPLA2G4AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343636-B2 | Crosslinkable hole-transporting materials for organic light-emitting devices | UNIVERSITY OF WASHINGTON (US) | 2013-01-01 | — | — | US | disclosed |
| US-20090278445-A1 | CROSSLINKABLE HOLE-TRANSPORTING MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | WASHINGTON, UNIVERSITY OF (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090278445-A1 | CROSSLINKABLE HOLE-TRANSPORTING MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | SUN2, HTT, SLC29A1 | PTGER4 2973/4885RORA 3497/4885RORC 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.